Literature DB >> 17577629

Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.

Haidong Gao1, Zhigang Yu, Dongsong Bi, Liyu Jiang, Yazhou Cui, Jingzhong Sun, Rong Ma.   

Abstract

Serine/threonine kinase Akt (also called protein kinase B, PKB) is a downstream effector of phosphoinositide 3-kinase (PI3K) and functions as the focal point for many signal transduction pathways such as glucose metabolism, transcription, cell survival, angiogenesis, and cell motility. Akt is emerging as a central player in tumorigenesis including human ovarian, pancreatic, prostate, breast, and gastric cancers. However, the function and mechanism by which Akt regulate gene transcription in nucleus remains largely unclear. Here we identify histone methyltransferase SETDB1 as a novel nuclear interacting partner of Akt. By yeast two-hybrid screening, we obtained the Akt1-SETDB1 interaction and confirmed the binding both in vitro and in vivo. Both Akt1 and SETDB1 are co-localized in the nucleus in mammalian cells. SETDB1 is not a phosphorylation substrate of Akt kinase. Akt and SETDB1 could coordinate to regulate the activity of certain transcription factors such as forkhead family member. Due to the fact that SETDB1 acts as a specific histone H3, lysine 9-methyltransferase in vivo, we provide the first link between Akt kinase and histone methyltransferase (HMTase). This interaction represents a novel mechanism by which Akt regulates nuclear events including gene transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577629     DOI: 10.1007/s11010-007-9525-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

Authors:  S I Matsuzawa; J C Reed
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

2.  The protooncogene TCL1 is an Akt kinase coactivator.

Authors:  J Laine; G Künstle; T Obata; M Sha; M Noguchi
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

3.  Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily.

Authors:  P F Jones; T Jakubowicz; F J Pitossi; F Maurer; B A Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 5.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

6.  AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

Authors:  M Sun; G Wang; J E Paciga; R I Feldman; Z Q Yuan; X L Ma; S A Shelley; R Jove; P N Tsichlis; S V Nicosia; J Q Cheng
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

Authors:  K Nakatani; D A Thompson; A Barthel; H Sakaue; W Liu; R J Weigel; R A Roth
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma.

Authors:  S P Staal; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

Review 10.  Epigenetics and cancer.

Authors:  Anders H Lund; Maarten van Lohuizen
Journal:  Genes Dev       Date:  2004-10-01       Impact factor: 11.361

View more
  10 in total

1.  Inhibition of cell proliferation by CD44: Akt is inactivated and EGR-1 is down-regulated.

Authors:  L-S Zhang; H-W Ma; H J Greyner; W Zuo; M E Mummert
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

2.  The Roles of the Methyl-CpG Binding Proteins in Cancer.

Authors:  Lee Parry; Alan R Clarke
Journal:  Genes Cancer       Date:  2011-06

3.  Bimodal regulation of FoxO3 by AKT and 14-3-3.

Authors:  Melissa Dobson; Gopalakrishnan Ramakrishnan; Stephanie Ma; Ludmila Kaplun; Vitaly Balan; Rafael Fridman; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2011-05-19

4.  Specific Akt Family Members Impair Stress-Mediated Transactivation of Viral Promoters and Enhance Neuronal Differentiation: Important Functions for Maintaining Latency.

Authors:  Jing Zhao; Liqian Zhu; Nishani Wijesekera; Clinton Jones
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

5.  Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.

Authors:  Atsushi Kaneda; Chiaochun J Wang; Raymond Cheong; Winston Timp; Patrick Onyango; Bo Wen; Christine A Iacobuzio-Donahue; Rolf Ohlsson; Rita Andraos; Mark A Pearson; Alexei A Sharov; Dan L Longo; Minoru S H Ko; Andre Levchenko; Andrew P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 6.  Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.

Authors:  Joachim Torrano; Abdullah Al Emran; Heinz Hammerlindl; Helmut Schaider
Journal:  Clin Epigenetics       Date:  2019-03-08       Impact factor: 6.551

7.  SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.

Authors:  Zexuan Liu; Junhao Liu; Behnam Ebrahimi; Uday P Pratap; Yi He; Kristin A Altwegg; Weiwei Tang; Xiaonan Li; Zhao Lai; Yidong Chen; Liangfang Shen; Gangadhara R Sareddy; Suryavathi Viswanadhapalli; Rajeshwar R Tekmal; Manjeet K Rao; Ratna K Vadlamudi
Journal:  Breast Cancer Res       Date:  2022-04-08       Impact factor: 6.466

8.  Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain-containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma.

Authors:  Maryam Ranjpour; Saima Wajid; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2021-03-08       Impact factor: 3.356

Review 9.  SETDB1 in cancer: overexpression and its therapeutic implications.

Authors:  Vanessa J Lazaro-Camp; Kiarash Salari; Xiangbing Meng; Shujie Yang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Integrated analysis of recurrent properties of cancer genes to identify novel drivers.

Authors:  Matteo D'Antonio; Francesca D Ciccarelli
Journal:  Genome Biol       Date:  2013-05-29       Impact factor: 13.583

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.